PLEOMORPHIC XANTHOASTROCYTOMA
Clinical trials for PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC XANTHOASTROCYTOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kids' brain tumor drugs tested for Long-Term safety
Disease control OngoingThis study follows 165 children who previously took dabrafenib and/or trametinib for certain brain tumors. Researchers want to see if these drugs are safe over the long term and how they affect growth. The children continue their treatment and are monitored for side effects and d…
Matched conditions: PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
1000 brain tumor Patients' records reviewed to see what worked
Knowledge-focused OngoingThis study is not testing a new treatment. Instead, researchers are reviewing medical records from 1000 adults with recurrent malignant gliomas (aggressive brain tumors) to see how well past chemotherapy and targeted therapies worked. The goal is to learn which treatments are lin…
Matched conditions: PLEOMORPHIC XANTHOASTROCYTOMA
Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC